Akero Therapeutics, Inc.

AKRONASDAQ Global Select·USD·Closed

AKRONASDAQ·USD·Closed

$54.65

+0.00%

$54.65

+$0.00 (0.00%)

52W Range

90thpctl

Volume

4.53×avg

Mkt Cap

4.50BUSD

P/E

-15.3TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

90thpctl

Volume

4.53×avg

Market Cap

4.50BUSD

P/E Ratio

-15.3TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-34.4%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-71.5×

Current ratio15.83×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required